Form 4/A for BVS Bioventus Inc.
Accepted 2023-08-23 00:00:00 ET · period of report 2023-08-16 · accession 0001578563-23-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2023-08-23 | 2023-08-16 | BVS | NOHRA GUY P | Dir | J - Other | $0.00 | -2.60M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-08-16 | J | D | 2,604,264 | $0.00 | 0 | I See Footnote | — | — | (F2) The reported shares are held by Alta Partners VIII, L.P. Alta Partners Management VIII, LLC is the general partner of Alta Partners VIII, L.P. The Reporting Person is one of the managing directors and a member of Alta Partners Management VIII, LLC and shares voting and dispositive power with respect to the shares held by Alta Partners VIII, L.P. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his proportionate pecuniary interest therein. |